Aurobindo Pharma Ltd. experiences stock price dip, experts give 'Buy' call

Aurobindo Pharma Ltd., a leading player in the pharmaceuticals and drugs industry, has recently seen a dip in its stock price. On September 20, 2024, the company's stock lost -3.16%, underperforming the sector by -3.3%. However, despite this recent decline, experts at MarketsMOJO have given a 'Buy' call for the stock. Taking a closer look at the price summary, we can see that Aurobindo Pharma Ltd. has been on a consecutive fall for the last 5 days, with a -4.64% decrease in returns during this period. The stock also touched an intraday low of Rs 1487.75, showing a -2.97% decline. While the stock's performance may seem concerning, it is worth noting that Aurobindo Pharma Ltd.'s moving averages are still higher than the 50 day, 100 day, and 200 day moving averages. However, it is currently lower than the 5 day and 20 day moving averages. In comparison to the overall market performance, Aurobindo Pharma Ltd. has underperformed the Sensex by -3.11% in the last 1 day and -3.10% in the last 1 month. Despite this, the company remains a strong player in the industry and has a positive outlook for the future. Investors can take advantage of the current dip in stock price and consider adding Aurobindo Pharma Ltd. to their portfolio.